Jim Tate


MIPS: All Is Not As It Appears

By Jim Tate – The MACRA/MIPS program is complex enough without having to decide what is real and what is not. I recently wrote a post entitled “Fake News – MIPS Style” and in the past week I have come across additional examples of misleading information that only serves to muddy the waters.


Fake News – MIPS Style

By Jim Tate – I sure hear a lot about fake news these days. In the world of politics, we hear a constant chant: “This is fake, that is fake, everything is fake”. I guess it is in the eye of the beholder as to what is true. There is the whole truth, the partial truth, misstatements of fact and downright Pinocchio lies.


MIPS 2017: Time Runneth Out

By Jim Tate – There is less than two weeks left on the clock. October 2nd is coming fast and brings the beginning of the last 90-day MIPS performance period for 2017. If plans have not already been made then this week is the last opportunity.


MIPS: Lawyers, Litigation, and Malpractice

By Jim Tate – Last week I documented yet another reason that the achievement of a high MIPS score should be Priority One for Eligible Clinicians. 2017 has been defined as the “Transition Year” for MACRA/MIPS and minimum standards have been put in place to allow minimal effort to avoid 2019 Part B adjustments.


MIPS: Loan Acquisition and Maintenance

By Jim Tate – We have reflected in earlier posts the critical importance of achieving a high MIPS score. Reimbursment, practice value, and professional reputation are all directly impacted by a MIPS score. Here is yet another collateral impact of a MIPS score: the ability to obtain and maintain a loan.